how long do you take a glp 1 GLP-1 for Weight Loss? Study: Many Patients Stop Weight

The drug is designed as a treatment for obesity, type 2 diabetes, and potentially other related metabolic disorders

Atrium can help patients prepare by documenting BMI, weight-related conditions, prior treatment history, medication tolerance, labs, and the clinical reason a GLP-1 is being considered

Tirzepatide (highest doses in SURMOUNT-1) produced average losses near or above 20%, depending on dose, with clear dose-response effects in pivotal trials

Presented at the 2025 Society of Hematologic Oncology Annual Meeting

An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function

Common dose schedule mistakes and how to avoid them Even with a clear dose schedule, researchers commonly make errors that undermine their results